NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
InspireMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.44−0.02 (-3.34%)
Close on Oct 19, 2026
- Market cap
- $37.25M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.8800 (−81.03%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
InspireMD, Inc. grew revenue 53.4% to $10.84M over the twelve months to Jun 30, 2026. Free cash flow was -$42.46M.
Revenue
$10.84M
+53.4% vs. a year earlier
Operating income
-$53.56M
TTM Q2 2026
Free cash flow
-$42.46M
TTM Q2 2026
EPS, diluted
-$0.76
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $37.25M
- P/E ratio
- –
- Price to sales
- 3.44
- Price to book
- 1.18
- Dividend yield
- –
- Free cash flow yield
- -113.99%
Fundamentals
- Revenue
- $10.84M
- Net income
- -$52.48M
- EPS, diluted
- -$0.76
- Free cash flow
- -$42.46M
- Book value per share
- $0.37
- Diluted shares
- 85M
Fifteen years at a glance
Fiscal years 2008 to 2025 and trailing twelve months, USD
Revenue
$10.84M+53.4% YoY
Gross profit
$1.96M+31.5% YoY
Operating income
-$53.56M
Net income
-$52.48M
EPS, diluted
–
Free cash flow
-$42.46M
Reported periodTrailing twelve months